Rezlidia
| Rezlidia | |
|---|---|
| Term | Rezlidia |
| Short definition | Rezlidia - (rez-LIH-dee-uh) A drug used to treat adults with acute myeloid leukemia that has come back or has not improved with other treatments and has a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Rezlidia - (rez-LIH-dee-uh) A drug used to treat adults with acute myeloid leukemia that has come back or has not improved with other treatments and has a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Rezlidhia blocks the protein made by the mutated IDH1 gene. Blocking this protein can help prevent cancer cells from growing. Rezlidhia is a type of enzyme inhibitor. Also called olutasidenib
External links
- Medical encyclopedia article on Rezlidia
- Wikipedia's article - Rezlidia
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski